————————————————————
The cornea is the clear front window of the eye, and when it scars, swells, or thins, glasses and contacts can no longer compensate. A corneal transplant (also called keratoplasty) replaces all or part of the cornea with healthy donor tissue, restoring useful vision in most patients. According to the Eye Bank Association of America (EBAA), tens of thousands of corneal transplants are performed in the United States each year — long reported at more than 80,000 annually — with overall one-year success rates commonly cited around 90 percent. Modern partial-thickness techniques have made recovery faster and rejection less common than the full-thickness operations of a generation ago. This article is general education, not medical advice; decisions about your eye belong to you and your corneal specialist.
What Corneal Transplant Surgery Is and Who Needs It
Donor corneas come from eye banks that screen tissue for infection and quality. The diseased portion of the recipient’s cornea is removed and replaced with donor tissue, which is either sutured in place or held against the back of the cornea by an internal gas bubble, depending on the technique used.
Common indications include keratoconus (a progressive thinning and bulging of the cornea), Fuchs endothelial dystrophy (failure of the inner corneal cell layer to pump fluid out, causing swelling), corneal scars from infection or trauma, bullous keratopathy after complicated cataract surgery, and chemical or thermal injuries. The American Academy of Ophthalmology (AAO) notes that endothelial keratoplasty (DSEK/DSAEK and DMEK) now accounts for the majority of US corneal transplants, in part because Fuchs dystrophy is among the leading reasons for surgery. Whether a transplant is the right step — and if so, which kind — is determined by a corneal specialist after a detailed examination.
Types of Corneal Transplant
Penetrating Keratoplasty (PK)
A full-thickness transplant. The diseased cornea is removed in a circular “button” and replaced with a matching donor button, typically held by around 16 to 24 sutures. Used for deep scars, advanced keratoconus, and full-thickness damage. Visual recovery often takes a year or more as sutures are gradually managed.
Deep Anterior Lamellar Keratoplasty (DALK)
Replaces the front layers of the cornea while preserving the patient’s own healthy endothelium (the innermost cell layer). Because the most antigenic layer stays in place, the risk of endothelial rejection is lower. Often used for keratoconus and anterior (front-layer) scars that spare the endothelium.
Descemet Stripping Endothelial Keratoplasty (DSEK / DSAEK)
Replaces only the inner endothelium along with a thin layer of supporting stroma. Used for Fuchs dystrophy and bullous keratopathy. Compared with PK, it generally offers faster recovery, fewer sutures, and a lower rejection risk.
Descemet Membrane Endothelial Keratoplasty (DMEK)
The thinnest and most precise endothelial transplant, replacing essentially just the endothelial cell layer and its membrane. Visual recovery is typically faster than DSEK and final acuity is often better, per comparative trial data. It is surgically demanding and not offered everywhere.
How the Procedure Is Performed
Most corneal transplants are outpatient procedures performed under local anesthesia with sedation, though general anesthesia is used in some cases. The surgeon numbs the eye (often with a peri-bulbar or similar block), places a lid speculum to keep the eye open, and works under an operating microscope. PK and DALK typically take roughly 45 to 90 minutes. DSEK and DMEK typically take about 30 to 60 minutes and use a gas bubble to press the thin donor tissue against the back of the cornea while it adheres.
Pre-operative evaluation commonly includes corneal topography, pachymetry (corneal thickness measurement), specular microscopy of the endothelium, and screening for active infection or uncontrolled glaucoma. Some patients need combined surgery — for example, cataract removal plus an endothelial transplant (a “triple procedure”) is common in older patients with Fuchs dystrophy. Patients exploring vision correction should also know that LASIK eye surgery is contraindicated in active keratoconus, which is why cross-linking or, when needed, DALK is the appropriate path for those patients rather than laser vision correction.
Recovery Timeline
Recovery depends heavily on the technique. DMEK patients are often asked to lie flat on their backs for a period after surgery (commonly on the order of 24 to 72 hours, per their surgeon’s instructions) so the gas bubble holds the graft in place. DSEK has similar but usually shorter positioning requirements. PK and DALK generally have no positioning requirement but call for a protective shield at night for several weeks.
Vision recovery varies dramatically by technique. DMEK patients often reach good vision within about four to eight weeks. DSEK commonly takes several months. PK can take roughly 12 to 18 months because sutures distort the cornea until they are gradually removed over the first year and beyond. Steroid eye drops are typically used long term — sometimes indefinitely at low doses — to reduce the risk of rejection, and this regimen is directed by your surgeon. Activities such as eye rubbing, contact sports, and swimming are typically restricted for a period after surgery (often one to three months, per your surgeon’s guidance). Driving usually resumes within a few weeks for endothelial transplants and later for PK, once vision and your surgeon allow.
Risks, Complications, and Outcomes
Graft survival at one year is commonly reported around 90 percent or higher for the endothelial techniques (DMEK and DSEK), roughly 90 percent for DALK, and somewhat lower for PK depending on the underlying disease, per sources such as the Cleveland Clinic and AAO. Longer-term survival declines over five and ten years, particularly for PK and for eyes with higher-risk features. Endothelial keratoplasty tends to have lower long-term rejection rates because less foreign tissue is exposed to the recipient’s immune system. These are population averages; your own prognosis depends on your diagnosis, eye health, and adherence to follow-up.
Possible complications include graft rejection (with lifetime risk varying by technique, generally lower for DMEK and higher for PK), infection, glaucoma, suture-related problems, primary graft failure, and astigmatism. With DMEK and DSEK, the donor tissue can detach early and require a “rebubble” procedure — reinjecting a gas bubble — in the office or operating room.
When to seek emergency care: Contact your corneal surgeon urgently or go to an eye emergency room if you experience sudden vision loss, severe eye pain, increasing redness, new light sensitivity, or a foreign-body sensation that worsens. A useful way to remember the warning signs of rejection is the acronym RSVP — Redness, Sensitivity to light, Vision changes, and Pain. Rejection is often reversible when caught early and treated promptly with intensive steroids, so do not wait to seek care.
Alternatives and Newer Approaches
Not every diseased cornea needs a transplant. Corneal collagen cross-linking can stabilize early-to-moderate keratoconus and help many patients avoid or delay surgery. Specialty contact lenses (scleral lenses, hybrid lenses) can rehabilitate vision in irregular corneas without surgery. For Fuchs dystrophy, approaches such as Descemet stripping only (in selected cases) and Rho kinase inhibitor eye drops have been studied as ways to encourage the eye’s own cells to recover. Artificial corneas (a keratoprosthesis such as the Boston KPro) are generally reserved for eyes that have failed multiple transplants. Patients are sometimes referred from a broader eye and systemic conditions evaluation to a corneal specialist to weigh these advanced options.
Cost Considerations
Corneal transplant is a medically necessary procedure and is generally covered by Medicare and most commercial insurance when clinically indicated. Without insurance, out-of-pocket costs can be substantial — often in the tens of thousands of dollars per eye — reflecting the eye-bank tissue fee, facility, surgeon, anesthesia, and the first year of follow-up. Costs vary meaningfully by region, technique, and whether other surgery (such as cataract removal) is combined. Our healthcare costs guide covers how to verify in-network status for the eye bank, surgeon, facility, and anesthesia separately, since each can generate a separate bill if not confirmed in advance. Always verify coverage and estimated cost with your plan and surgeon’s office before scheduling.
Frequently Asked Questions
How long does a corneal transplant last?
It depends on the technique and the underlying disease. Endothelial transplants (DSEK and DMEK) commonly report strong survival at five years, while PK survival tends to decline more over five and ten years. Many transplants last many years or decades, while some eyes need a repeat procedure sooner. Your surgeon can give you a more specific expectation for your situation.
Can the cornea be rejected?
Yes. Lifetime rejection risk varies by technique — generally lower with DMEK and higher with PK. Most rejection episodes respond to intensive steroid drops if caught and treated early, which is why recognizing the RSVP warning signs matters. Long-term low-dose steroid drops help reduce the risk.
Will I need glasses after a corneal transplant?
Most patients still need glasses or contact lenses for their best vision. PK in particular often induces significant astigmatism that may require rigid contact lenses. DMEK patients frequently do well with simple glasses, and some need little correction. Your final result depends on the technique and your eye.
How soon can I work after surgery?
Desk work is often possible within a week or two for DSEK and DMEK, and a bit longer for PK and DALK, but this depends on your recovery and your surgeon’s guidance. Heavy, dusty, or dirty work environments usually require more time off because of infection and injury risk.
Where do donor corneas come from?
Donor corneas are recovered and processed by eye banks that screen tissue for infectious disease and assess its quality before release. In the US, this system is coordinated in part through the Eye Bank Association of America. Thanks to donation, the US generally has a reliable supply of corneal tissue for transplantation.
The bottom line: Corneal transplant surgery has become more nuanced and more successful over the past couple of decades thanks to partial-thickness techniques like DMEK, DSEK, and DALK. Ask your corneal specialist which technique best fits your specific disease, what their graft-failure and rebubble rates are, what positioning you’ll need, and what the long-term steroid-drop plan looks like. Learn the rejection warning signs — RSVP: Redness, Sensitivity to light, Vision change, Pain — and seek care urgently if they appear. Matching the right technique to your cornea, and staying on top of follow-up, is the single biggest predictor of a smooth recovery. This article is educational only; your corneal specialist decides what’s right for your eye.
Sources
- Eye Bank Association of America (EBAA) — annual statistical reporting on US corneal transplantation and eye banking
- American Academy of Ophthalmology (AAO) — Corneal Transplant patient information
- Cleveland Clinic — Corneal Transplant (Keratoplasty)
- National Eye Institute (NEI) — Corneal Conditions